View Older Stories View More Recent Stories

May 22, 2014 06:38AM Roth Capital Downgrades Keurig Green Mountain (GMCR) to Neutral
May 19, 2014 06:42AM Roth Trims PT, Ests on Canadian Solar (CSIQ); Execution in Canada, Japan Now Key
May 16, 2014 01:49PM Hydrogenics Corp. (HYGS) Closes 1.5M Share Offering Priced at $15/sh
May 16, 2014 07:52AM Roth Capital Keeps Stemline (STML) at 'Buy'; Still Plenty to See and Do in 2014
May 16, 2014 06:56AM Roth Capital Starts Top Image Systems (TISA) at Buy
May 15, 2014 04:51PM Sphere 3D to Acquire Overland Storage (OVRL) in All-Stock Deal
May 15, 2014 08:40AM Roth Capital Starts Magellan Petroleum (MPET) at Buy
May 15, 2014 08:38AM Roth Slashes PT on Plug Power (PLUG) to $3.75; Amid Positive Outlook, Several Areas Still Need Addressing
May 15, 2014 08:14AM Roth Affirms Rexahn (RNN) at 'Buy'; Things Shaping Up for Solid Second-Half 2014
May 14, 2014 02:59PM Roth Boosts PT on Coronado (CNDO) to $1.70; Sidelined Until TSO, CNDO-109 Trajectory Clears Up
May 14, 2014 08:34AM Roth Capital Upgrades Summer Infant (SUMR) to Buy
May 13, 2014 09:20AM Roth Keeps Cytori Therapeutics (CYTX) at 'Buy'; Still Encouraged by Streamlining Efforts
May 13, 2014 06:59AM Roth Trims PT on Orion Energy Systems (OESX) to $6; LED Hiccup Doesn't Disrupt Story
May 12, 2014 06:38AM Roth Capital Upgrades Neogenomics (NEO) to Buy
May 9, 2014 10:47AM Roth Reiterates 'Sell' Rating, $1 PT on Dendreon (DNDN) Following Q1 Report; Totality of Risks Remain High
May 9, 2014 06:49AM Roth Capital Downgrades Diamondback Energy (FANG) to Neutral
May 8, 2014 02:51PM Roth Boosts Ests on JA Solar (JASO) Following Q1 Results
May 8, 2014 02:18PM Curis' (CRIS) Q1 Results Flat; Erivedge Growth, Pipeline Remain in Focus - Roth
May 8, 2014 11:22AM Keryx (KERX) Volatility Could Increase on Zerenex PDUFA Date Delay, but Risk Negligible - Roth
May 8, 2014 10:42AM Notable Analyst Rating Changes 05/08: (SCTY) (YELP) (FOSL) Upgraded; (MRK) (AGN) (PENN) Downgraded
May 8, 2014 09:21AM Roth Capital Downgrades PowerSecure (POWR) to Neutral
May 8, 2014 08:47AM SolarCity (SCTY) Continues Making Demonstrated Material Progress; Roth Upgrades to 'Buy'
May 8, 2014 08:45AM Roth Capital Upgrades SolarCity (SCTY) to Buy
May 7, 2014 11:49AM Roth Affirms Ligand Pharma (LGND) at 'Buy'; Captisol, Promacta Lead Strong Q1 Results
May 7, 2014 10:23AM Roth Keeps Galena (GALE) at 'Buy' Following Q1 Report; Still Bullish on Abstral Following Revenue Results
May 7, 2014 09:58AM Roth Slashes PT on Dendreon (DNDN) to $1; Multiple Hurdles Still Exist
May 7, 2014 09:53AM Residential Bookings, Retained Value/Watt Key for SolarCity (SCTY) into Q1 Report - Roth
May 7, 2014 09:29AM Cytokinetics' (CYTK) Q1 Results Solid, BENEFIT Remains in Focus - Roth
May 7, 2014 08:01AM Roth Capital Upgrades Hecla Mining (HL) to Buy
May 6, 2014 09:10AM Roth Capital Upgrades Golden Minerals Company (AUMN) to Buy
May 5, 2014 02:54PM Roth Positive on MEI Pharma (MEIP) Following ME-344 Phase 1b Initiation
May 5, 2014 11:37AM Pharmacyclics (PCYC) Story Unchanged Following Q1 Report; Roth Reiterates at 'Buy'
May 2, 2014 06:55AM Roth Capital Upgrades Maxwell Technologies (MXWL) to Buy
May 1, 2014 10:41AM Celldex (CLDX) Upcoming Clinical Data, Study Expansions, Pipeline Keep Roth Positive; 'Focus List' Rating Affirmed
May 1, 2014 10:14AM Roth Comments on Palatin's (PTN) BMT Agreement with European Partner; Reaffirms 'Buy' Rating
Apr 30, 2014 03:22PM Viggle, Inc. (VGGL) Closes 4.38M Common Offering for Gross Proceeds of $35M
Apr 30, 2014 02:48PM Roth Positive on Cytokinetics (CYTK) Following BENEFIT-ALS Update; Several Points Go in Tirasemtiv's Favor
Apr 30, 2014 10:00AM Roth Affirms Ligand (LGND) at Buy; FDA Grants Promacta/Revolade Priority Review
Apr 30, 2014 07:51AM Roth Capital Upgrades Trinity Biotech (TRIB) to Buy
Apr 29, 2014 10:16AM New BENEFIT-ALS Data from Cytokinetics (CYTK) is 'Exciting'; Investors Should Regain Confidence - Roth
Apr 29, 2014 08:45AM Roth Capital Downgrades Ultra Clean (UCTT) to Neutral
Apr 28, 2014 10:09AM DoD Supporting Galena's (GALE) NeuVax Provides Important Third-Party Scientific Validation - Roth
Apr 25, 2014 12:28PM Viggle, Inc. (VGGL) NASDAQ Uplisting/IPO Opens Lower
Apr 25, 2014 09:35AM Roth Slashes PT on Cytokinetics (CYTK) to $13; ALS Call Missed, but Omecamtiv Provides Buffer
Apr 25, 2014 08:47AM Viggle, Inc. (VGGL) Prices Larger 4.38M Common Offering at $8 Apiece
Apr 24, 2014 10:28AM Zerenex Costs Savings, Differentiation Highlighted; PDUFA Date Still in Focus (KERX) - Roth Capital
Apr 23, 2014 09:56AM Roth 'Encouraged' to See Bavituximab Moving Forward; Affirms Peregrine Pharma (PPHM) at 'Buy'
Apr 22, 2014 09:43AM Roth Capital Pounds Table on Cytokinetics (CYTK) into AAN BENEFIT-ALS Presentation
Apr 22, 2014 06:37AM Roth Capital Starts GSV Capital (GSVC) at Buy
Apr 21, 2014 10:40AM Notable Analyst Rating Changes 04/21: (MS) (AWI) (HNI) Upgraded; (WLT) (MGI) (YUM) Downgraded
View More Recent Stories View Older Stories